TG-6050

N/A

Report date: 2025/07/11 20:01:15

Base Information

Drug NameTG-6050
Drug Alias NameTG-6050
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-12 stimulantsAnti-CTLA4
TargetsInterleukin-12Cytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTransgene Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene Sa
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A